A phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor in the intensification of cisplatin and cyclophosphamide chemotherapy for advanced ovarian...

por Kehoe, S., Poole, C. J., Stanley, A., Earl, H. M., Blackledge, G. R.
Publicado 1994

Multicentre cross over study of aminoglutethimide and trilostane in advanced postmenopausal breast cancer.

por Williams, C. J., Barley, V. L., Blackledge, G. R., Rowland, C. G., Tyrrell, C. J.
Publicado 1993

A negative phase II trial methylene dimethane sulphonate in advanced ovarian cancer (Cancer Research Campaign Phase I/II Trials Committee).

por Smith, D. B., Lind, M. J., Kaye, S. B., Newlands, E. S., Blackledge, G. R., Gibson, A.
Publicado 1988

Peritoneal trauma releases CA125?

por Redman, C. W., Jones, S. R., Luesley, D. M., Nicholl, S. E., Kelly, K., Buxton, E. J., Chan, K. K., Blackledge, G. R.
Publicado 1988

The role of metoclopramide in acute and delayed chemotherapy induced emesis: a randomised double blind trial.

por O'Brien, M. E., Cullen, M. H., Woodroffe, C., Kelly, K., Burman, C., Palmer, K., Stuart, N. S., Blackledge, G. R., Sharpe, J.
Publicado 1989

Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856).

por Newlands, E. S., Blackledge, G. R., Slack, J. A., Rustin, G. J., Smith, D. B., Stuart, N. S., Quarterman, C. P., Hoffman, R., Stevens, M. F., Brampton, M. H.
Publicado 1992